TK Hoffmann, K Nakano, EM Elder, G Dworacki, SD Finkelstein, E Appella, TL Whiteside, AB DeLeo. (2000) " Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants. " J Immunol 165. 5938-44 PMID: 11067956 | Abstract and Keywords

TK Hoffmann, DJ Loftus, K Nakano, MJ Maeurer, K Chikamatsu, E Appella, TL Whiteside, AB DeLeo. (2002) " The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope. " J Immunol 168. 1338-47 PMID: 11801674 | Abstract and Keywords

TK Hoffmann, AD Donnenberg, SD Finkelstein, VS Donnenberg, U Friebe-Hoffmann, EN Myers, E Appella, AB DeLeo, TL Whiteside. (2002) " Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer. " Cancer Res 62. 3521-9 PMID: 12067999 | Abstract and Keywords

AE Albers, RL Ferris, GG Kim, K Chikamatsu, AB DeLeo, TL Whiteside. (2005) " Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites. " Cancer Immunol Immunother 54. 1072-81 PMID: 15959774 DOI: 10.1007/s00262-005-0670-9 | Abstract and Keywords

SJ Antonia, N Mirza, I Fricke, A Chiappori, P Thompson, N Williams, G Bepler, G Simon, W Janssen, JH Lee, K Menander, S Chada, DI Gabrilovich. (2006) " Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. " Clin Cancer Res 12. 878-87 PMID: 16467102 DOI: 10.1158/1078-0432.CCR-05-2013 | Abstract and Keywords

VR Cicinnati, X Zhang, Z Yu, S Ferencik, KJ Schmitz, G Dworacki, E Kaczmarek, K Oldhafer, A Frilling, HA Baba, KW Schmid, H Grosse-Wilde, CE Broelsch, AB DeLeo, G Gerken, S Beckebaum. (2006) " Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma. " Int J Cancer 119. 2851-60 PMID: 16998881 DOI: 10.1002/ijc.22251 | Abstract and Keywords

D Ito, A Albers, YX Zhao, C Visus, E Appella, TL Whiteside, AB DeLeo. (2006) " The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells. " J Immunol 177. 6795-803 PMID: 17082593 | Abstract and Keywords

AE Albers, C Schaefer, C Visus, W Gooding, AB DeLeo, TL Whiteside. (2009) " Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer. " Head Neck 31. 773-81 PMID: 19296526 DOI: 10.1002/hed.21031 | Abstract and Keywords

OE Rahma, E Ashtar, M Czystowska, ME Szajnik, E Wieckowski, S Bernstein, VE Herrin, MA Shams, SM Steinberg, M Merino, W Gooding, C Visus, AB Deleo, JK Wolf, JG Bell, JA Berzofsky, TL Whiteside, SN Khleif. (2011) " A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients. " Cancer Immunol Immunother 61. 373-84 PMID: 21927947 DOI: 10.1007/s00262-011-1100-9 | Abstract and Keywords